Codiak BioSciences (CDAK): SEC Form 3 filed by new insider Mauro David J
Stocks in this Quantisnow insightHealth Care
Keep researching CDAK
- CDAK insider tradesEvery buy and sale reported by Codiak BioSciences Inc. officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
CDAK
Codiak BioSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Get push alerts for CDAK
Full CDAK profile on Quantisnow Follow CDAK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time